EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP)

BACKGROUND: Long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP) was approved by the U.S. Food and Drug Administration in December 2021. This initial phase of implementation represents a prime opportunity to ensure equitable LAI-PrEP provision to communities often underrepresented in PrEP...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaul, Christina M., Moore, Brandi E., Kaplan-Lewis, Emma, Casey, Eunice, Pitts, Robert A., Pagan Pirallo, Patricia, Lim, Sahnah, Kapadia, Farzana, Cohen, Gabriel M., Khan, Maria, Mgbako, Ofole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508596/
https://www.ncbi.nlm.nih.gov/pubmed/37725628
http://dx.doi.org/10.1371/journal.pone.0291657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508596/
https://www.ncbi.nlm.nih.gov/pubmed/37725628
http://dx.doi.org/10.1371/journal.pone.0291657

Ejemplares similares